StockWatch
·
Pharmaceuticals
Quarterly Result13 Aug 2026, 07:09 pm

Panacea Biotec Declares Unaudited Q1 FY27 Results

AI Summary

Panacea Biotec Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results, which have undergone a limited review by statutory auditors. The company also announced the date for its 42nd Annual General Meeting on September 29, 2026, and the closure of the Register of Members and Share Transfer Books from September 25 to September 29, 2026, for the AGM. Mr. Debabrata Deb Nath has been appointed as Scrutinizer for the e-voting process.

Key Highlights

  • Unaudited financial results for Q1 FY27 declared.
  • Standalone and consolidated results approved by the Board.
  • Limited review by statutory auditors completed.
  • 42nd Annual General Meeting scheduled for September 29, 2026.
  • Register of Members closed from September 25-29, 2026.